Guoqing Zang
- Hepatology top 5%
- Hepatitis C virus research 11
- Epidemiology top 10%
- Hepatitis B Virus Studies 33
- Liver Disease Diagnosis and Treatment 5
-
- Immunotherapy and Immune Responses 21
- interferon and immune responses 4
- Pharmacology top 10%
-
- RNA Interference and Gene Delivery 6
- Ubiquitin and proteasome pathways 6
- vaccines and immunoinformatics approaches 5
- Cited by
- HepatologyEpidemiologyImmunology
- Journals
- SHILAP Revista de lepidopterología (1 paper)PLoS ONE (1 paper)Scientific Reports (1 paper)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Guoqing Zang
64 papers receiving 883 citations
Peers
Comparison fields: 5 of 90
- Hepatology 254
- Epidemiology 413
- Immunology 210
- Pharmacology 47
- Cancer Research 78
Countries citing papers authored by Guoqing Zang
This map shows the geographic impact of Guoqing Zang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoqing Zang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoqing Zang more than expected).
Fields of papers citing papers by Guoqing Zang
This network shows the impact of papers produced by Guoqing Zang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoqing Zang. The network helps show where Guoqing Zang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guoqing Zang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 6 | |
| 2 | 2023 | 4 | |
| 3 | 2022 | 1 | |
| 4 | 2022 | 11 | |
| 5 | 2020 | 14 | |
| 6 | 2019 | 31 | |
| 7 | 2019 | 27 | |
| 8 | 2018 | 12 | |
| 9 | 2016 | 11 | |
| 10 | 2015 | 14 | |
| 11 | Clinical analysis of 26 cases with cryptococcal meningitis | 2014 | 0 |
| 12 | 2014 | 4 | |
| 13 | 2014 | 6 | |
| 14 | 2012 | 25 | |
| 15 | 2012 | 15 | |
| 16 | 2010 | 68 | |
| 17 | 2010 | 23 | |
| 18 | Changes and clinical significance of serum retinol-binding protein and prealbumin in patients with viral hepatitis B | 2009 | 1 |
| 19 | Clinical analysis of 128 patients with the fever of unknown origin | 2007 | 0 |
| 20 | 2004 | 4 |
About Guoqing Zang
Guoqing Zang is a scholar working on Hepatology, Immunology and Epidemiology, having authored 67 papers that have together received 893 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (33 papers), Immunotherapy and Immune Responses (21 papers), Hepatitis C virus research (11 papers), RNA Interference and Gene Delivery (6 papers), Ubiquitin and proteasome pathways (6 papers), vaccines and immunoinformatics approaches (5 papers), Liver Disease Diagnosis and Treatment (5 papers) and interferon and immune responses (4 papers). The work is most often cited by research in Hepatology (254 citations), Epidemiology (413 citations) and Immunology (210 citations). Guoqing Zang has collaborated with scholars based in China, United States and India. Frequent co-authors include Yongsheng Yu, Zhenghao Tang, Xiaohua Chen, Zhenghao Tang, Qingchun Pan, Yi Zhang, Meng Zhuo, Siyuan Ma, Yuyan Tang and Shanshan Wu. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.